skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 22,153  for All Library Resources

Sorted by: Sorted by: Date-newestOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Caregiver‐reported quality of communication in pancreatic and periampullary cancer
Caregiver‐reported quality of communication in pancreatic and periampullary cancer
Material Type:
Article 		Add to My Research

Caregiver‐reported quality of communication in pancreatic and periampullary cancer

Cancer, 2024-06, Vol.130 (11), p.2051-2059 [Peer Reviewed Journal]

2023 American Cancer Society. ;2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35154 ;PMID: 38146683

Digital Resources/Online E-Resources

Citations Cited by
2
Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt
Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt
Material Type:
Article 		Add to My Research

Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt

Cancer, 2024-06, Vol.130 (11), p.1952-1963 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35214 ;PMID: 38244208

Digital Resources/Online E-Resources

Citations Cited by
3
Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era
Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era
Material Type:
Article 		Add to My Research

Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era

Cancer, 2024-06, Vol.130 (11), p.2031-2041 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35230 ;PMID: 38294959

Digital Resources/Online E-Resources

Citations Cited by
4
Cancer Statistics 2024: Deaths drop, incidences increase, prevention needed
Cancer Statistics 2024: Deaths drop, incidences increase, prevention needed
Material Type:
Article 		Add to My Research

Cancer Statistics 2024: Deaths drop, incidences increase, prevention needed

Cancer, 2024-06, Vol.130 (11), p.1904-1904 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35347 ;PMID: 38757629

Digital Resources/Online E-Resources

Citations Cited by
5
A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancer
A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancer
Material Type:
Article 		Add to My Research

A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancer

Cancer, 2024-06, Vol.130 (11), p.1916-1929 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35285 ;PMID: 38529566

Digital Resources/Online E-Resources

Citations Cited by
6
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome
Material Type:
Article 		Add to My Research

Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome

Cancer, 2024-06, Vol.130 (11), p.1964-1971 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35251 ;PMID: 38340331

Digital Resources/Online E-Resources

Citations Cited by
7
Physical activity and pain in people with and without cancer
Physical activity and pain in people with and without cancer
Material Type:
Article 		Add to My Research

Physical activity and pain in people with and without cancer

Cancer, 2024-06, Vol.130 (11), p.2042-2050 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35208 ;PMID: 38343307

Digital Resources/Online E-Resources

Citations Cited by
8
Associations of serum trimethylamine N‐oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort
Associations of serum trimethylamine N‐oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort
Material Type:
Article 		Add to My Research

Associations of serum trimethylamine N‐oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort

Cancer, 2024-06, Vol.130 (11), p.1982-1990 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35219 ;PMID: 38285606

Digital Resources/Online E-Resources

Citations Cited by
9
Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study
Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study
Material Type:
Article 		Add to My Research

Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study

Cancer, 2024-06, Vol.130 (11), p.1991-2002 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35226 ;PMID: 38404184

Digital Resources/Online E-Resources

Citations Cited by
10
Age at diagnosis and social risks among Black cancer survivors: Results from the Detroit Research on Cancer Survivors cohort
Age at diagnosis and social risks among Black cancer survivors: Results from the Detroit Research on Cancer Survivors cohort
Material Type:
Article 		Add to My Research

Age at diagnosis and social risks among Black cancer survivors: Results from the Detroit Research on Cancer Survivors cohort

Cancer, 2024-06, Vol.130 (11), p.2060-2073 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35212 ;PMID: 38280205

Digital Resources/Online E-Resources

Citations Cited by
11
Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE)
Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE)
Material Type:
Article 		Add to My Research

Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE)

Cancer, 2024-06, Vol.130 (11), p.1930-1939 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35221 ;PMID: 38340349

Digital Resources/Online E-Resources

Citations Cited by
12
Glofitamab as a salvage treatment for B‐cell lymphomas in the real world: A multicenter study in Taiwan
Glofitamab as a salvage treatment for B‐cell lymphomas in the real world: A multicenter study in Taiwan
Material Type:
Article 		Add to My Research

Glofitamab as a salvage treatment for B‐cell lymphomas in the real world: A multicenter study in Taiwan

Cancer, 2024-06, Vol.130 (11), p.1972-1981 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35217 ;PMID: 38306242

Digital Resources/Online E-Resources

Citations Cited by
13
Effect of a 1‐year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors—A randomized controlled trial (SURfit)
Effect of a 1‐year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors—A randomized controlled trial (SURfit)
Material Type:
Article 		Add to My Research

Effect of a 1‐year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors—A randomized controlled trial (SURfit)

Cancer, 2024-05, Vol.130 (10), p.1869-1883 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35207 ;PMID: 38315522

Digital Resources/Online E-Resources

Citations Cited by
14
Determinants of active surveillance uptake in a diverse population‐based cohort of men with low‐risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS)
Determinants of active surveillance uptake in a diverse population‐based cohort of men with low‐risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS)
Material Type:
Article 		Add to My Research

Determinants of active surveillance uptake in a diverse population‐based cohort of men with low‐risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS)

Cancer, 2024-05, Vol.130 (10), p.1797-1806 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35190 ;PMID: 38247317

Digital Resources/Online E-Resources

Citations Cited by
15
Detection of circulating plasma cells in peripheral blood using deep learning‐based morphological analysis
Detection of circulating plasma cells in peripheral blood using deep learning‐based morphological analysis
Material Type:
Article 		Add to My Research

Detection of circulating plasma cells in peripheral blood using deep learning‐based morphological analysis

Cancer, 2024-05, Vol.130 (10), p.1884-1893 [Peer Reviewed Journal]

2023 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2023 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35202 ;PMID: 38236717

Digital Resources/Online E-Resources

Citations Cited by
16
Effect of home‐based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial
Effect of home‐based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial
Material Type:
Article 		Add to My Research

Effect of home‐based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial

Cancer, 2024-05, Vol.130 (10), p.1858-1868 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35204 ;PMID: 38265970

Digital Resources/Online E-Resources

Citations Cited by
17
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable‐risk prostate cancer
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable‐risk prostate cancer
Material Type:
Article 		Add to My Research

The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable‐risk prostate cancer

Cancer, 2024-05, Vol.130 (10), p.1766-1772 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35215 ;PMID: 38280206

Digital Resources/Online E-Resources

Citations Cited by
18
Late mortality among 5‐year survivors of childhood cancer: A systematic review and meta‐analysis
Late mortality among 5‐year survivors of childhood cancer: A systematic review and meta‐analysis
Material Type:
Article 		Add to My Research

Late mortality among 5‐year survivors of childhood cancer: A systematic review and meta‐analysis

Cancer, 2024-05, Vol.130 (10), p.1844-1857 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35213 ;PMID: 38271115

Digital Resources/Online E-Resources

Citations Cited by
19
Incorporating patient‐reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients
Incorporating patient‐reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients
Material Type:
Article 		Add to My Research

Incorporating patient‐reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients

Cancer, 2024-05, Vol.130 (10), p.1826-1835 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35189 ;PMID: 38198511

Digital Resources/Online E-Resources

Citations Cited by
20
A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers
A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers
Material Type:
Article 		Add to My Research

A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers

Cancer, 2024-05, Vol.130 (10), p.1784-1796 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35200 ;PMID: 38261444

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 22,153  for All Library Resources

Sorted by: Sorted by: Date-newestOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1964  (107)
  2. 1964 To 1978  (3,305)
  3. 1979 To 1993  (7,483)
  4. 1994 To 2009  (7,050)
  5. After 2009  (4,228)
  6. More options open sub menu

Subject 

  1. Male  (22,117)
  2. Humans  (21,884)
  3. Oncology  (18,905)
  4. Life Sciences & Biomedicine  (18,506)
  5. Science & Technology  (18,506)
  6. Female  (16,940)
  7. Middle Aged  (14,970)
  8. Aged  (12,660)
  9. Adult  (12,516)
  10. Biological And Medical Sciences  (11,879)
  11. Medical Sciences  (11,862)
  12. Tumors  (6,351)
  13. Adolescent  (4,770)
  14. Prognosis  (4,719)
  15. Aged, 80 And Over  (3,900)
  16. Child  (3,301)
  17. Cancer Research  (2,901)
  18. Retrospective Studies  (2,426)
  19. Neoplasm Staging  (2,307)
  20. Follow-Up Studies  (2,229)
  21. More options open sub menu

Language 

  1. Japanese  (2,938)
  2. German  (26)
  3. Russian  (2)
  4. Norwegian  (2)
  5. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait